Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Previous years crawled date : 2020 - 12 - 01 save search
Leading Independent Proxy Firms ISS and Glass Lewis Recommend Ocugen Stockholders Vote “FOR” Reverse Stock Split and Authorized Shares Amendment Proposals
Published: 2020-12-01 (Crawled : 23:01) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: -9.46%
H: 5.23%
C: 3.38%
glass ev authorized
POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer
Published: 2020-03-31 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: -6.59%
H: 12.35%
C: -7.34%
cancer ovarian cancer
Predictive Oncology Reports 2019 Full-year Financial Results
Published: 2020-04-01 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: -6.68%
H: 5.1%
C: -4.76%
results
Predictive Oncology Exchanges $2.1 Million of Debt for Equity, Streamlining Capital Structure and Simplifying Balance Sheet
Published: 2020-04-22 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 0.72%
H: 4.31%
C: -5.4%
Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
Published: 2020-05-06 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 30.14%
H: 2.63%
C: -21.05%
collaboration covid vaccine potential
Predictive Oncology Announces $2.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2020-05-07 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: -10.0%
H: 1.48%
C: -4.44%
offering nasdaq
Predictive Oncology (NASDAQ Symbol POAI) is licensing and partnering this groundbreaking NSP10 technology in the race to develop a vaccine for development
Published: 2020-05-14 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 13.67%
H: 0.0%
C: -11.39%
license vaccine
Predictive Oncology Completes Acquisition of Soluble Therapeutics and BioDtech
Published: 2020-06-02 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 3.12%
H: 1.82%
C: 1.82%
biotech acquisition therapeutics
Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update
Published: 2020-06-08 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: -1.65%
H: 7.26%
C: 2.23%
results
Predictive Oncology’s TumorGenesis Division Secures First Commercial Sale of its Novel Ovarian Cancer Cell Media
Published: 2020-06-18 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 6.98%
H: 13.04%
C: 8.15%
cancer ovarian cancer commercialization
Predictive Oncology Inc. Announces Receipt of Cash Proceeds of $2.2 Million from Exercise of Warrants
Published: 2020-06-29 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 0.0%
H: 2.34%
C: -4.09%
Predictive Oncology Completes Acquisition of Quantitative Medicine
Published: 2020-07-07 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 3.4%
H: 7.89%
C: 2.63%
acquisition
Predictive Oncology Refreshes Board with Appointment of Three New Directors
Published: 2020-07-14 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 4.17%
H: 1.33%
C: -4.0%
Predictive Oncology Issues Letter to Shareholders
Published: 2020-08-11 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: -10.0%
H: 4.58%
C: 2.61%
Predictive Oncology Reports Second Quarter 2020 Financial Results, Provides Business Update
Published: 2020-08-13 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: -8.45%
H: 8.38%
C: 3.85%
results
Predictive Oncology’s Skyline Medical Sells 8 STREAMWAY® Systems to a Large University Hospital Organization in Virginia; 13 STREAMWAY® Systems Sold Halfway Into Q3 2020
Published: 2020-08-18 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 3.08%
H: 5.97%
C: -7.46%
system
Soluble Biotech Announces First Contract with a Major Pharmaceutical Company for Protein Expression and Solubility Studies
Published: 2020-08-20 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 0.0%
H: 3.42%
C: -3.42%
biotech contract first contract
Predictive Oncology Inc to Present at LD Micro's "LD 500" Virtual Investor Conference on Wednesday, September 02, 2020 3:40 PM Eastern Time
Published: 2020-09-01 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: -0.86%
H: 4.35%
C: 1.04%
Predictive Oncology Secures License for an Additional 71 Unique Ovarian Cancer Cell Lines from Ximbio, Cancer Research UK’s Premier Reagents Distributor
Published: 2020-09-22 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 25.34%
H: 8.49%
C: -6.92%
license cancer research ovarian cancer
Predictive Oncology CEO Letter to Shareholders
Published: 2020-10-06 (Crawled : 22:17) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 4.62%
H: 2.49%
C: -1.27%
ceo leo
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.